Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Projected Cost-effectiveness of Smoking Cessation Interventions in Patients Hospitalized With Myocardial Infarction

Projected Cost-effectiveness of Smoking Cessation Interventions in Patients Hospitalized With... ORIGINAL INVESTIGATION Projected Cost-effectiveness of Smoking Cessation Interventions in Patients Hospitalized With Myocardial Infarction Joseph A. Ladapo, MD, PhD; Farouc A. Jaffer, MD, PhD; Milton C. Weinstein, PhD; Erika Sivarajan Froelicher, RN, PhD Background: As many as 70% of smokers with acute pitalized smokers would create 50 230 new quitters, cost myocardial infarction (AMI) continue to smoke after hos- $27.3 million in nurse wages and materials, and prevent pital discharge despite high rates of inpatient smoking 1380 nonfatal AMIs and 7860 deaths. During a 10-year cessation counseling. Supportive contact after dis- period, it would save $22.1 million in reduced hospital- charge improves quit rates but is rarely used. izations but increase health care costs by $166.4 mil- lion, primarily through increased longevity. Productiv- Methods: Using data from a meta-analysis of random- ity costs from premature death would fall by $1.99 billion ized trials of smoking cessation interventions and other and nonmedical expenditures would increase by $928 mil- published sources, we developed a Monte Carlo model lion, for a net positive value to society of $894 million. to project health and economic outcomes for a hypo- The program would cost $540 per quitter considering only thetical US cohort of 327 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Internal Medicine American Medical Association

Projected Cost-effectiveness of Smoking Cessation Interventions in Patients Hospitalized With Myocardial Infarction

Download PDF
7 pages

Loading next page...
 
/lp/american-medical-association/projected-cost-effectiveness-of-smoking-cessation-interventions-in-WgJKox8eoM

References (61)

Publisher
American Medical Association
Copyright
Copyright 2011 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6106
eISSN
2168-6114
DOI
10.1001/archinternmed.2010.479
pmid
21220659
Publisher site
See Article on Publisher Site

Abstract

ORIGINAL INVESTIGATION Projected Cost-effectiveness of Smoking Cessation Interventions in Patients Hospitalized With Myocardial Infarction Joseph A. Ladapo, MD, PhD; Farouc A. Jaffer, MD, PhD; Milton C. Weinstein, PhD; Erika Sivarajan Froelicher, RN, PhD Background: As many as 70% of smokers with acute pitalized smokers would create 50 230 new quitters, cost myocardial infarction (AMI) continue to smoke after hos- $27.3 million in nurse wages and materials, and prevent pital discharge despite high rates of inpatient smoking 1380 nonfatal AMIs and 7860 deaths. During a 10-year cessation counseling. Supportive contact after dis- period, it would save $22.1 million in reduced hospital- charge improves quit rates but is rarely used. izations but increase health care costs by $166.4 mil- lion, primarily through increased longevity. Productiv- Methods: Using data from a meta-analysis of random- ity costs from premature death would fall by $1.99 billion ized trials of smoking cessation interventions and other and nonmedical expenditures would increase by $928 mil- published sources, we developed a Monte Carlo model lion, for a net positive value to society of $894 million. to project health and economic outcomes for a hypo- The program would cost $540 per quitter considering only thetical US cohort of 327

Journal

JAMA Internal Medicine – American Medical Association

Published: Jan 10, 2011

There are no references for this article.